NOXAFIL is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Posaconazole.
Product ID | 0085-1328_125b529c-3a8d-4672-8264-da4834fabe79 |
NDC | 0085-1328 |
Product Type | Human Prescription Drug |
Proprietary Name | NOXAFIL |
Generic Name | Posaconazole |
Dosage Form | Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2006-09-15 |
Marketing Category | NDA / NDA |
Application Number | NDA022003 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | POSACONAZOLE |
Active Ingredient Strength | 40 mg/mL |
Pharm Classes | Azole Antifungal [EPC],Azoles [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2006-09-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022003 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2006-09-15 |
Ingredient | Strength |
---|---|
POSACONAZOLE | 40 mg/mL |
SPL SET ID: | b073b082-7b57-4423-8c06-4fd4263d6f84 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0085-1328 | NOXAFIL | posaconazole |
0085-2224 | NOXAFIL | posaconazole |
0085-4324 | NOXAFIL | posaconazole |
0085-4331 | NOXAFIL | posaconazole |
0254-2045 | POSACONAZOLE | posaconazole |
0406-7711 | POSACONAZOLE | posaconazole |
0527-2133 | POSACONAZOLE | Posaconazole |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NOXAFIL 77007334 3825429 Live/Registered |
MERCK SHARP & DOHME CORP. 2006-09-25 |
NOXAFIL 75731165 2468349 Live/Registered |
MERCK SHARP & DOHME CORP. 1999-06-17 |
NOXAFIL 75217327 not registered Dead/Abandoned |
SCHERING CORPORATION 1996-12-23 |